File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1124/jpet.110.170688
- Scopus: eid_2-s2.0-78649549070
- PMID: 20837990
- WOS: WOS:000284308800016
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Dexmedetomidine induces both relaxations and contractions, via different α2-adrenoceptor subtypes, in the isolated mesenteric artery and aorta of the rat
Title | Dexmedetomidine induces both relaxations and contractions, via different α2-adrenoceptor subtypes, in the isolated mesenteric artery and aorta of the rat | ||||||
---|---|---|---|---|---|---|---|
Authors | |||||||
Issue Date | 2010 | ||||||
Publisher | American Society for Pharmacology and Experimental Therapeutics. The Journal's web site is located at http://jpet.aspetjournals.org | ||||||
Citation | Journal Of Pharmacology And Experimental Therapeutics, 2010, v. 335 n. 3, p. 659-664 How to Cite? | ||||||
Abstract | Dexmedetomidine is an α2-adrenoceptor agonist and anesthetic. The present study was designed to characterize the receptor subtypes and the downstream mechanisms of the vascular effects of dexmedetomidine in small (mesenteric artery) and large (aorta) arteries ex vivo. Isometric tension was measured in Sprague-Dawley rat mesenteric and aortic rings (with or without endothelium). To study relaxations, cumulative concentrations of dexmedetomidine, 5-bromo-N-(2-imidazolin-2-yl)-6-quinoxalinamine, (UK14304), or clonidine were added to rings contracted with 9,11-dideoxy-9α,11α- methanoepoxy prostaglandin F2α (U46619) in the presence or absence of indomethacin; Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME); 2-[2H-(1-methyl-1,3-dihydroisoindole)methyl]-4,5- dihydroimidazole maleate (BRL44408); 2-[2-(4-(2-methoxyphenyl)piperazin-1-yl) ethyl]-4,4-dimethyl-1,3-(2H,4H)-isoquinolindione dihydrochloride (ARC239); L-657,743, (2S-trans)-1,3,4,5′,6,6′,7,12b-octahydro-1′, 3′-dimethyl-spiro[2H-benzofuro[2,3-a]quinolizine-2,4′(1′H) -pyrimidin]-2′(3′H)-one hydrochloride hydrate (MK912); rauwolscine; prazosin; or pertussis toxin. To study contractions, dexmedetomidine was added to quiescent rings without endothelium or after incubation with L-NAME, rauwolscine, prazosin, indomethacin, or 3-[(6-amino-(4-chlorobenzensulfonyl)-2- methyl-5,6,7,8-tetrahydronaphth)-1-yl]propionic acid (S18886). Dexmedetomidine evoked relaxation at low concentrations (10 pM-30 nM) followed by contraction at higher concentrations (>30 nM) in the mesenteric artery. In the aorta, the relaxation was significantly smaller. The relaxation to dexmedetomidine depended on nitric oxide, endothelium, and Gi protein, and it was mediated by α2A/D-adrenoceptors and possibly α2B- adrenoceptors. The contraction was mediated mainly by α2B- and α1-adrenoceptors and involved the action of prostanoids. UK14304 and clonidine induced greater and smaller relaxations, respectively, than dexmedetomidine. In conclusion, depending on the concentration used and the presence of functional endothelium, dexmedetomidine may evoke both relaxation and contraction in isolated arteries. The vascular effects also vary depending on the blood vessel studied. Its vascular effect is different from that of clonidine and UK14304. Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics. | ||||||
Persistent Identifier | http://hdl.handle.net/10722/135343 | ||||||
ISSN | 2023 Impact Factor: 3.1 2023 SCImago Journal Rankings: 0.829 | ||||||
ISI Accession Number ID |
Funding Information: This work was supported in part by the general research fund of the Research Grants Council of Hong Kong [Grant HKU 773509M] and a University of Hong Kong Seed Funding for Basic Research Grant [Grant 200710159019] and partly by departmental funds. | ||||||
References | |||||||
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wong, ESW | en_HK |
dc.contributor.author | Man, RYK | en_HK |
dc.contributor.author | Vanhoutte, PM | en_HK |
dc.contributor.author | Ng, KFJ | en_HK |
dc.date.accessioned | 2011-07-27T01:33:55Z | - |
dc.date.available | 2011-07-27T01:33:55Z | - |
dc.date.issued | 2010 | en_HK |
dc.identifier.citation | Journal Of Pharmacology And Experimental Therapeutics, 2010, v. 335 n. 3, p. 659-664 | en_HK |
dc.identifier.issn | 0022-3565 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/135343 | - |
dc.description.abstract | Dexmedetomidine is an α2-adrenoceptor agonist and anesthetic. The present study was designed to characterize the receptor subtypes and the downstream mechanisms of the vascular effects of dexmedetomidine in small (mesenteric artery) and large (aorta) arteries ex vivo. Isometric tension was measured in Sprague-Dawley rat mesenteric and aortic rings (with or without endothelium). To study relaxations, cumulative concentrations of dexmedetomidine, 5-bromo-N-(2-imidazolin-2-yl)-6-quinoxalinamine, (UK14304), or clonidine were added to rings contracted with 9,11-dideoxy-9α,11α- methanoepoxy prostaglandin F2α (U46619) in the presence or absence of indomethacin; Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME); 2-[2H-(1-methyl-1,3-dihydroisoindole)methyl]-4,5- dihydroimidazole maleate (BRL44408); 2-[2-(4-(2-methoxyphenyl)piperazin-1-yl) ethyl]-4,4-dimethyl-1,3-(2H,4H)-isoquinolindione dihydrochloride (ARC239); L-657,743, (2S-trans)-1,3,4,5′,6,6′,7,12b-octahydro-1′, 3′-dimethyl-spiro[2H-benzofuro[2,3-a]quinolizine-2,4′(1′H) -pyrimidin]-2′(3′H)-one hydrochloride hydrate (MK912); rauwolscine; prazosin; or pertussis toxin. To study contractions, dexmedetomidine was added to quiescent rings without endothelium or after incubation with L-NAME, rauwolscine, prazosin, indomethacin, or 3-[(6-amino-(4-chlorobenzensulfonyl)-2- methyl-5,6,7,8-tetrahydronaphth)-1-yl]propionic acid (S18886). Dexmedetomidine evoked relaxation at low concentrations (10 pM-30 nM) followed by contraction at higher concentrations (>30 nM) in the mesenteric artery. In the aorta, the relaxation was significantly smaller. The relaxation to dexmedetomidine depended on nitric oxide, endothelium, and Gi protein, and it was mediated by α2A/D-adrenoceptors and possibly α2B- adrenoceptors. The contraction was mediated mainly by α2B- and α1-adrenoceptors and involved the action of prostanoids. UK14304 and clonidine induced greater and smaller relaxations, respectively, than dexmedetomidine. In conclusion, depending on the concentration used and the presence of functional endothelium, dexmedetomidine may evoke both relaxation and contraction in isolated arteries. The vascular effects also vary depending on the blood vessel studied. Its vascular effect is different from that of clonidine and UK14304. Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics. | en_HK |
dc.language | eng | en_US |
dc.publisher | American Society for Pharmacology and Experimental Therapeutics. The Journal's web site is located at http://jpet.aspetjournals.org | en_HK |
dc.relation.ispartof | Journal of Pharmacology and Experimental Therapeutics | en_HK |
dc.subject.mesh | Aorta - drug effects | - |
dc.subject.mesh | Dexmedetomidine - pharmacology | - |
dc.subject.mesh | Mesenteric Arteries - drug effects | - |
dc.subject.mesh | Muscle Contraction - drug effects | - |
dc.subject.mesh | Muscle Relaxation - drug effects | - |
dc.title | Dexmedetomidine induces both relaxations and contractions, via different α2-adrenoceptor subtypes, in the isolated mesenteric artery and aorta of the rat | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Man, RYK: rykman@hkucc.hku.hk | en_HK |
dc.identifier.email | Vanhoutte, PM: vanhoutt@hku.hk | en_HK |
dc.identifier.email | Ng, KFJ: jkfng@hkucc.hku.hk | en_HK |
dc.identifier.authority | Man, RYK=rp00236 | en_HK |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_HK |
dc.identifier.authority | Ng, KFJ=rp00544 | en_HK |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1124/jpet.110.170688 | en_HK |
dc.identifier.pmid | 20837990 | - |
dc.identifier.scopus | eid_2-s2.0-78649549070 | en_HK |
dc.identifier.hkuros | 186072 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-78649549070&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 335 | en_HK |
dc.identifier.issue | 3 | en_HK |
dc.identifier.spage | 659 | en_HK |
dc.identifier.epage | 664 | en_HK |
dc.identifier.isi | WOS:000284308800016 | - |
dc.publisher.place | United States | en_HK |
dc.relation.project | Vascular effects of dexmedetomidine | - |
dc.identifier.scopusauthorid | Wong, ESW=37035429000 | en_HK |
dc.identifier.scopusauthorid | Man, RYK=7004986435 | en_HK |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_HK |
dc.identifier.scopusauthorid | Ng, KFJ=13608809400 | en_HK |
dc.identifier.issnl | 0022-3565 | - |